Navigation Links
Geisinger research: Antimalarial drug prevents diabetes in arthritis patients
Date:10/28/2008

DANVILLE, PA - The use of an antimalarial medication may prevent the onset of diabetes in patients with rheumatoid arthritis, new Geisinger research shows.

Researchers examined the records of 2,093 Geisinger patients who received treatment for rheumatoid arthritis from 2000 to 2008. The study looked at, among other things, use of the medication hydroxychloroquine (HCQ) and the development of new cases of diabetes in these patients.

HCQ was developed to treat malaria but it has also been used to treat rheumatoid arthritis and other autoimmune diseases.

In patients with rheumatoid arthritis, use of HCQ was associated with a 53 percent reduction in the development of new cases of diabetes, the study found.

"Given the relative safety and low cost of this generic drug, HCQ may be useful in preventing diabetes in other high risk groups," said lead study investigator and Geisinger rheumatologist Androniki Bili, MD, MPH.

Researchers don't know how exactly HCQ prevents diabetes onset but it's suspected that HCQ improves glucose tolerance.

Dr. Bili presented the study's findings Monday at the American College of Rheumatology Annual Scientific Meeting in San Francisco.

About 23.6 million Americans have diabetes, while 1.3 million have rheumatoid arthritis.

People with rheumatoid arthritis are at increased risk for diabetes due to more sedentary lifestyle, chronic inflammation and use of steroid medications that can cause weight gain.

"We should revisit HCQ in the treatment of rheumatoid arthritis because, in addition to its disease-modifying properties, it might prevent the development of diabetes in this high risk group," Dr. Bili said.


'/>"/>

Contact: Justin Walden
jawalden@geisinger.edu
570-271-8083
Geisinger Health System
Source:Eurekalert

Page: 1

Related biology news :

1. Geisinger piloting innovative laboratory specimen processing instrument
2. Geisinger study: Inflammatory disease causes blindness
3. Robotics research: Enhancing the lives of people with disabilities
4. Advances in the field of schizophrenia research: New genetic factors identified
5. New research: Fruit juice consumption not related to overweight in children
6. Paradigm shift in Alzheimerss research: new treatments
7. Resveratrol prevents fat accumulation in livers of alcoholic mice
8. Anti-cancer drug prevents, reverses cardiovascular damage in mouse model of premature aging disorder
9. Chemical compound prevents cancer in lab
10. A compound extracted from olives inhibits cancer cells growth and prevents their appearance
11. Device prevents potential errors in childrens medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2014)... 2014) – A majority of Madagascar,s 101 species of ... serious consequences for the rainforests they call home. A ... impacts lemurs can have on rainforest tree populations, which ... have on the region,s rich biodiversity. , A large ... by lemurs. Lemurs in turn disperse the seeds ...
(Date:11/3/2014)... Center study published in this month,s ... the activity of a recently discovered communication molecule of ... has been known to limit inflammation and the current ... IL-37 inhibits the ability of the immune system to ... that underlies IL-37,s effect on the immune system now ...
(Date:11/2/2014)... In this month,s issue of Physics World , ... bridging the "valley of death" to take their innovations ... argues that the gruelling challenge facing all start-up companies ... harder for physicists because of two main factors: physics-based ... and they often turn out to be a lot ...
Breaking Biology News(10 mins):Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3PNAS: From HIV to cancer, IL-37 regulates immune system 2The 'valley of death' facing physics start-ups 2
... developed at the Hebrew University of Jerusalem that is ... led to approval by the U.S. Food and Drug ... cardiac surgery patients. The product is the ... biodegradable polymers for the prevention of post-surgical adhesions. SyntheMed ...
... available in German . , Helsinki/Leipzig. ... trading, will only be successful if they are coherently ... issues, says a report published today by the Partnership ... from seven of the biggest European environmental research institutes. ...
... Both plant and human diseases that can travel ... more rapidly than has been understood, according to a ... only for some human diseases but also a new ... done by scientists at Oregon State University and other ...
Cached Biology News:Hebrew University professor's work leads to FDA approval for product 2Climate change aims need to be better integrated 2New wheat disease could spread faster than expected 2New wheat disease could spread faster than expected 3
(Date:11/24/2014)... , Nov. 24, 2014  Spherix Incorporated (Nasdaq: ... committed to the fostering and monetization of intellectual ... VTech Telecommunications Ltd.,  Case No. 3:13-cv-03494-M and  Spherix ... 3:13-cv-03496-M, both in the United States District Court ... . On November 21, ...
(Date:11/22/2014)... (PRWEB) November 21, 2014 Two new educational ... what comes next for ALS research and how the pharmaceutical ... After the Ice Bucket Challenge: Where Does the ALS Money ... Tuesday, 2 December 2014, Time: 1:30pm ET, Register ... expert speaker Dr. Merit Cudkowicz, Julianne Dorn Professor of Neurology ...
(Date:11/22/2014)... Colo. (PRWEB) November 21, 2014 ... proprietary cloud based analytics and scientific testing methodologies relating ... commitment for a $750,000 line of credit from an ... extremely pleased to have secured this commitment from one ... Executive Officer of CannLabs. “This capital will help accelerate ...
(Date:11/22/2014)... The “Chiral Chromatography Columns Market by ... Glass, Plastic), by Application [GC, LC (HPLC, UHPLC, ... 2018” analyses and studies the major market drivers, ... Asia, and Rest of the World. , Browse ... through 135 pages and in-depth TOC on “Chiral ...
Breaking Biology Technology:Markman Hearing Held as Scheduled in VTech and Uniden Cases 2DrugDev Webinars in December to Explore What Comes Next for ALS Research and How We Can Make Life Easier for Clinical Sites 2CannLabs Secures $750,000 Line Of Credit 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 2Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 3Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 4Chiral Chromatography Columns Market worth $87.8 Million by 2018 - New Research Report by MarketsandMarkets 5
... Inc. (Nasdaq: NVAX ) today announced that it ... press release to be issued after 8:00 a.m. Eastern Time ... investor conference call to discuss its financial results at 10:00 ... will be hosted by Novavax President and Chief Executive Officer ...
... May 4 The Arcas Group, a ... Stefan Terwindt, MBA as Executive Vice President. He will ... Terwindt previously served as President of Imedex, Inc."Stefan is ... and skills to our company," said Founder and President ...
... & Company, LLC, a Boston-based life science investment bank, ... has joined the firm as senior advisor. In ... on internal and client-related activities including private equity placements ... focus on medical device transactions. "We are thrilled ...
Cached Biology Technology:Novavax Announces Release Date of 2009 First Quarter, Financial Results and Investor Conference Call 2The Arcas Group Appoints Executive Vice President 2Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company 2